Skip to main content
. 2019 May 25;14(6):595–608. doi: 10.1016/j.ajps.2019.04.004

Fig. 4.

Fig 4

The applications of A7R. (A) A7R was used as an antiangiogenic and anticancer agent. (B) Radiolabeled A7R. The A7R peptide is covalently conjugated to radionuclides. (C) A7R peptides or peptidomimetics are grafted at the nanocarrier surface (liposomes, nanoparticles, etc.). These nanocarriers are loaded with various drugs, such as anticancer therapeutic drugs, peptides, proteins, or nucleic acids.